12:00 AM
Nov 04, 2013
 |  BC Week In Review  |  Company News  |  Management Tracks

Teva management update

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel
Business: Autoimmune, Neurology, Biosimilars

Read the full 44 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >